Ann: Emyria Completes Acquisition of the Pax Centre, page-4

I’m struggling to figure out which has more Potential IHL or EMD….for short term Shareholder growth opportunities.

Both are fantastic companies with a pipeline of development Drugs & services to hopefully benefit many many millions of customers & clients in need, if they are successful….

They both seem way undervalued & a further Buy, although still a risky punt?.

The current Top-up / Entry point looks very attractive & possibly a Bargain for Both.

I will be taking up my full entitlement of shares in EMD, but would also like to invest more in IHL.

Keen to know others thoughts.

Regards